MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer-Reference-Cited by-同舟云学术

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

Published:2004-10 Issue:7012 Volume:431 Page:1112-1117
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Shachaf Catherine M.,Kopelman Andrew M.,Arvanitis Constadina,Karlsson Åsa,Beer Shelly,Mandl Stefanie,Bachmann Michael H.,Borowsky Alexander D.,Ruebner Boris,Cardiff Robert D.,Yang Qiwei,Bishop J. Michael,Contag Christopher H.,Felsher Dean W.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature03043.pdf

Reference30 articles.

1. Nowak, A. K., Chow, P. K. & Findlay, M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur. J. Cancer 40, 1474–1484 (2004)

2. Bishop, J. M. Molecular themes in oncogenesis. Cell 64, 235–248 (1991)

3. Felsher, D. W. Cancer revoked: oncogenes as therapeutic targets. Nature Rev. Cancer 3, 375–380 (2003)

4. Jain, M. et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297, 102–104 (2002)

5. Coleman, W. B. Mechanisms of human hepatocarcinogenesis. Curr. Mol. Med. 3, 573–588 (2003)

Cited by 763 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

2. Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges;Biomedicines;2024-07-22

3. De novo and salvage purine synthesis pathways across tissues and tumors;Cell;2024-07

4. MicroRNA miR-20a-5p targets CYCS to inhibit apoptosis in hepatocellular carcinoma;Cell Death & Disease;2024-06-27

5. Aberrant differentiation and proliferation of hepatocytes in chronic liver injury and liver tumors;Pathology International;2024-06-05